Not Tagged
Not Tagged
['breast']
there is a clear need for new agents to decrease relapse from hormone receptor-positive breast cancer. are cdk inhibitors the answer? from our breast disease section editor presenting this morning at #asco22 
An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)